Total Payments
$89,280
2024 Payments
$23,620
Companies
17
Transactions
67
Medicare Patients
1,468
Medicare Billing
$201,659
Payment Breakdown by Category
Consulting$55,346 (62.0%)
Other$25,750 (28.8%)
Travel$6,282 (7.0%)
Food & Beverage$1,725 (1.9%)
Education$178.06 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $55,346 | 18 | 62.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,975 | 5 | 25.7% |
| Travel and Lodging | $6,282 | 16 | 7.0% |
| Honoraria | $2,775 | 2 | 3.1% |
| Food and Beverage | $1,725 | 23 | 1.9% |
| Education | $178.06 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $23,573 | 13 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $20,128 | 12 | $0 (2024) |
| SOBI, INC | $13,202 | 8 | $0 (2023) |
| PFIZER INC. | $9,523 | 10 | $0 (2024) |
| GENZYME CORPORATION | $9,050 | 6 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $4,360 | 4 | $0 (2024) |
| Agios Pharmaceuticals, Inc. | $2,775 | 2 | $0 (2023) |
| Alnylam Pharmaceuticals Inc. | $2,760 | 1 | $0 (2024) |
| Janssen Global Services, LLC | $2,180 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,250 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,620 | 17 | Alexion Pharmaceuticals, Inc. ($16,128) |
| 2023 | $21,161 | 14 | PFIZER INC. ($7,062) |
| 2022 | $16,889 | 13 | Sobi, Inc ($10,427) |
| 2021 | $1,013 | 4 | GENZYME CORPORATION ($851.00) |
| 2020 | $13,326 | 5 | Novartis Pharmaceuticals Corporation ($10,586) |
| 2019 | $11,134 | 10 | Novartis Pharmaceuticals Corporation ($10,962) |
| 2017 | $2,137 | 4 | PFIZER INC. ($2,137) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/15/2023 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $2,180.00 | General |
| 07/27/2023 | SOBI, INC | Doptelet (Drug) | Consulting Fee | Cash or cash equivalent | $2,775.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 06/27/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $82.41 | General |
| Category: Diabetes | ||||||
| 05/10/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $47.32 | General |
| 05/04/2023 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $115.69 | General |
| Category: Hematology | ||||||
| 04/25/2023 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $2,940.00 | General |
| 10/28/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $52.09 | General |
| Category: Rare Disease | ||||||
| 10/20/2022 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Honoraria | Cash or cash equivalent | $1,942.50 | General |
| Category: Genetically Defined Disease | ||||||
| 07/28/2022 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $2,025.00 | General |
| 07/15/2022 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $39.24 | General |
| Category: HEMATOLOGY | ||||||
| 06/28/2022 | GENZYME CORPORATION | SARCLISA (Biological) | Consulting Fee | Cash or cash equivalent | $2,265.00 | General |
| Category: Oncology | ||||||
| 06/28/2022 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $137.98 | General |
| Category: Oncology | ||||||
| 04/21/2022 | Sobi, Inc | DOPTELET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,200.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 04/02/2022 | Sobi, Inc | DOPTELET (Drug) | Travel and Lodging | Cash or cash equivalent | $723.59 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 04/02/2022 | Sobi, Inc | DOPTELET (Drug) | Travel and Lodging | Cash or cash equivalent | $166.10 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 04/02/2022 | Sobi, Inc | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $49.94 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 04/02/2022 | Sobi, Inc | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $34.89 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 04/02/2022 | Sobi, Inc | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 04/01/2022 | Sobi, Inc | DOPTELET (Drug) | Travel and Lodging | Cash or cash equivalent | $235.27 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $121.15 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2021 | Astellas Pharma US Inc | XOSPATA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: ONCOLOGY | ||||||
| 06/18/2021 | Astellas Pharma US Inc | XOSPATA (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: ONCOLOGY | ||||||
| 05/25/2021 | GENZYME CORPORATION | CABLIVI (Biological) | Consulting Fee | Cash or cash equivalent | $851.00 | General |
| Category: Hematology | ||||||
| 12/14/2020 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Consulting Fee | Cash or cash equivalent | $1,965.00 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2020 | GENZYME CORPORATION | CABLIVI (Biological) | Consulting Fee | Cash or cash equivalent | $2,740.00 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 385 | 676 | $139,781 | $55,145 |
| 2022 | 6 | 320 | 622 | $132,519 | $53,911 |
| 2021 | 7 | 382 | 609 | $111,179 | $48,796 |
| 2020 | 7 | 381 | 634 | $106,295 | $43,808 |
Total Patients
1,468
Total Services
2,541
Medicare Billing
$201,659
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 74 | 105 | $10,290 | $4,279 | 41.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 26 | 26 | $6,500 | $2,785 | 42.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 29 | 40 | $5,920 | $2,380 | 40.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 12 | 13 | $2,587 | $1,099 | 42.5% |
About Dr. Michael Jaglal, MD
Dr. Michael Jaglal, MD is a Internal Medicine healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417024746.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Jaglal, MD has received a total of $89,280 in payments from pharmaceutical and medical device companies, with $23,620 received in 2024. These payments were reported across 67 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($55,346).
As a Medicare-enrolled provider, Jaglal has provided services to 1,468 Medicare beneficiaries, totaling 2,541 services with total Medicare billing of $201,659. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist, Hematology & Oncology
- Location Tampa, FL
- Active Since 11/30/2006
- Last Updated 06/02/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1417024746
Products in Payments
- PROMACTA (Drug) $14,770
- DOPTELET (Drug) $10,427
- OXBRYTA (Drug) $7,386
- ADAKVEO (Biological) $6,778
- ULTOMIRIS (Biological) $4,185
- CABLIVI (Biological) $3,707
- Doptelet (Drug) $2,775
- PYRUKYND (Drug) $2,775
- GIVLAARI (Drug) $2,760
- SARCLISA (Biological) $2,403
- ELIQUIS (Drug) $2,137
- XARELTO (Drug) $1,250
- UBRELVY (Drug) $121.15
- GVOKE HYPOPEN (Drug) $82.41
- IMBRUVICA (Drug) $76.95
- XOSPATA (Drug) $40.91
- MONOFERRIC (Drug) $39.24
- HEMGENIX (Biological) $17.92
- Rezlidhia (Drug) $6.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tampa
Javier Pinilla-Ibarz, Md, MD
Internal Medicine — Payments: $1.9M
Internal Medicine $1.9M
Alberto Chiappori, Md, MD
Internal Medicine — Payments: $617,120
Internal Medicine $617,120
Ricardo Restrepo-Jaramillo, M.d, M.D
Internal Medicine — Payments: $562,511
Internal Medicine $562,511
Dr. Sady Alpizar, Md, MD
Internal Medicine — Payments: $509,824
Internal Medicine $509,824
Jhanelle Gray, Md, MD
Internal Medicine — Payments: $273,892
Internal Medicine $273,892
Dr. Andrew Kuykendall, M.d, M.D
Internal Medicine — Payments: $273,357
Internal Medicine $273,357